Atlas Trials

SAfety and TOlerance of the Biopsies in Auto-immune Rare dIseases

Clinical trial NCT05022420 · TERMINATED

Trial details

NCT number
NCT05022420
Sponsor
University Hospital, Brest
Status
TERMINATED
Study type
OBSERVATIONAL
ToleranceBiopsy Site Itching
Start date
2021-08-19
Primary completion
2025-03-16
Enrollment
505

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.